Achieving a Good Crystal System for Crystallographic X-Ray Fragment Screening-Reference-Cited by-同舟云学术

Achieving a Good Crystal System for Crystallographic X-Ray Fragment Screening

Published:2018 Issue: Volume: Page:251-264
ISSN:0076-6879
Container-title:Methods in Enzymology
language:
Short-container-title:

Author:

Collins Patrick M.,Douangamath Alice,Talon Romain,Dias Alexandre,Brandao-Neto Jose,Krojer Tobias,von Delft Frank

Publisher

Elsevier

Reference22 articles.

1. Gentle, fast and effective crystal soaking by acoustic dispensing;Collins;Acta Crystallographica. Section D, Structural Biology,2017

2. Crystallization to obtain protein-ligand complexes for structure-aided drug design. Acta Crystallographica. Section D;Danley;Biological Crystallography,2006

3. Microseed matrix screening for optimization in protein crystallization: what have we learned? Acta Crystallographica. Section F;D'Arcy;Structural Biology Communications,2014

4. An allosteric binding site of the alpha7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein;Delbart;The Journal of Biological Chemistry,2018

5. Synthesis and demonstration of the biological relevance of sp(3)-rich scaffolds distantly related to natural product frameworks;Foley;Chemistry,2017

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data Science;Cancer Discovery;2023-09-15

2. Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search;Journal of Chemical Information and Modeling;2023-05-25

3. Halo Library, a Tool for Rapid Identification of Ligand Binding Sites on Proteins Using Crystallographic Fragment Screening;Journal of Medicinal Chemistry;2023-04-28

4. Fragment-based Ligand Discovery (FBLD);The Handbook of Medicinal Chemistry;2023-02-03

5. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2;Proceedings of the National Academy of Sciences;2023-01-04